FR2417982B1 - - Google Patents

Info

Publication number
FR2417982B1
FR2417982B1 FR7904626A FR7904626A FR2417982B1 FR 2417982 B1 FR2417982 B1 FR 2417982B1 FR 7904626 A FR7904626 A FR 7904626A FR 7904626 A FR7904626 A FR 7904626A FR 2417982 B1 FR2417982 B1 FR 2417982B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7904626A
Other versions
FR2417982A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOVEX FOREIGN TRADE CO Ltd
Original Assignee
NOVEX FOREIGN TRADE CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOVEX FOREIGN TRADE CO Ltd filed Critical NOVEX FOREIGN TRADE CO Ltd
Publication of FR2417982A1 publication Critical patent/FR2417982A1/fr
Application granted granted Critical
Publication of FR2417982B1 publication Critical patent/FR2417982B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7904626A 1978-02-24 1979-02-23 Produit pharmaceutique solide contenant un sel de bismuth, administrable par voie orale, presentant un taux d'activite accru et un taux de solubilite constant et predetermine Granted FR2417982A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78GA1247A HU179474B (en) 1978-02-24 1978-02-24 Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material

Publications (2)

Publication Number Publication Date
FR2417982A1 FR2417982A1 (fr) 1979-09-21
FR2417982B1 true FR2417982B1 (fr) 1984-11-30

Family

ID=10996479

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7904626A Granted FR2417982A1 (fr) 1978-02-24 1979-02-23 Produit pharmaceutique solide contenant un sel de bismuth, administrable par voie orale, presentant un taux d'activite accru et un taux de solubilite constant et predetermine

Country Status (8)

Country Link
US (1) US4199560A (fr)
JP (1) JPS54135219A (fr)
AU (1) AU521699B2 (fr)
CA (1) CA1113393A (fr)
CH (1) CH639845A5 (fr)
DE (1) DE2907215A1 (fr)
FR (1) FR2417982A1 (fr)
HU (1) HU179474B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
US4937076A (en) * 1984-08-10 1990-06-26 Combe Incorporated Chewable aspirin and buffering material tablet and method for producing same
AT388101B (de) * 1985-02-05 1989-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung
JPS62502967A (ja) * 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー 非潰瘍消化不良症の治療
EP0462631B1 (fr) * 1985-06-13 1996-03-20 Barry James Dr. Marshall Procédés et composés pour le traitement des désordres gastro-instestinaux
DE3686361T3 (de) * 1985-06-13 2003-01-09 Barry James Marshall Verwendung von Bismuth zur Herstellung von Medikamenten zur Behandlung von Magen-Darmstörungen, die von Campylobacter polyridis verursacht sind.
US4670248A (en) * 1985-08-15 1987-06-02 International Minerals & Chemical Corp. Olivine bolus
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
HU196711B (en) * 1986-06-24 1989-01-30 Istvan Racz Process for producing long-acting, gastric acid neutralizing pharmaceutics with high acid-binding capacity and increased bioavailability
US4656028A (en) * 1986-06-24 1987-04-07 Norcliff Thayer Inc. Encapsulated antacid
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
DK0540613T3 (da) * 1990-07-20 1996-04-01 Tillotts Pharma Ag Produkter og fremgangsmåder til behandling af fordøjelseskanalen
EP0484106A1 (fr) * 1990-11-01 1992-05-06 Merck & Co. Inc. Compositions à libération contrôlée
US5368862A (en) * 1991-12-18 1994-11-29 Merck & Co., Inc. Sustained release tablets containing alginate
DE69322077T2 (de) * 1992-03-25 1999-04-08 Depomed Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
SE507682C2 (sv) * 1996-03-29 1998-07-06 Marcin Krotkiewski Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
FR2779651B1 (fr) * 1998-06-16 2001-04-20 Gattefosse Ets Sa Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20090142398A1 (en) * 2007-11-21 2009-06-04 Pharmascience Inc. Novel pharmaceutical compositions comprising a disintegration matrix

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166868A (en) * 1936-03-02 1939-07-18 Columbus Pharmacal Company Colloidal aluminum hydroxide
US2146867A (en) * 1937-06-07 1939-02-14 Welin Sater Company Medicinal preparation and method of making the same
US2836540A (en) * 1952-03-19 1958-05-27 Hardt Foundation Pharmaceutical antacid composition
US2774710A (en) * 1952-12-15 1956-12-18 Organon Pharmaceutical preparation for the treatment of hyperacidity
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2854376A (en) * 1954-09-07 1958-09-30 Hardt Foundation Antacid composition
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3175942A (en) * 1962-03-13 1965-03-30 Evans Medical Ltd Gastro-intestinal therapeutic
US3362880A (en) * 1963-09-20 1968-01-09 Dow Chemical Co Compressed drug tablets of ethyl cellulose, glyceryl monostearate, karaya gum, tragacanth, talc, and magnesium stearate
US3555151A (en) * 1966-12-21 1971-01-12 Richardson Merrell Inc Long acting solid antacid
US3579634A (en) * 1968-04-18 1971-05-18 Garland Richard Brown Novel antacid compositions and methods for their administration
US3579635A (en) * 1969-10-08 1971-05-18 Lilly Co Eli Antibiotic treatment of ruminant animals with bis-urea adducts of aldehyde-containing macrolide antibiotics
DE1963496A1 (de) * 1969-12-18 1971-06-24 Hans Voigt Chemisch Pharmazeut Pharmazeutisches Praeparat zur Behandlung von Magen-Darm-Erkrankungen
FR2146915A1 (en) * 1971-07-26 1973-03-09 Cerm Cent Europ Rech Mauvernay Basic bismuth salts of xanthane gums - as pharmaceutical excipients
GB1390683A (en) * 1972-12-18 1975-04-16 Biorex Laboratories Ltd Pharmaceutical composition
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions

Also Published As

Publication number Publication date
AU521699B2 (en) 1982-04-22
JPS54135219A (en) 1979-10-20
CH639845A5 (en) 1983-12-15
AU4454579A (en) 1979-08-30
DE2907215A1 (de) 1979-09-06
FR2417982A1 (fr) 1979-09-21
US4199560A (en) 1980-04-22
HU179474B (en) 1982-10-28
CA1113393A (fr) 1981-12-01

Similar Documents

Publication Publication Date Title
FR2417982B1 (fr)
FR2415119B1 (fr)
DE2850309C2 (fr)
FR2414188B1 (fr)
FR2414512B1 (fr)
FR2413565B1 (fr)
FR2413867B1 (fr)
DE2828097C2 (fr)
AU3898778A (fr)
DE2823378C2 (fr)
FR2414132B1 (fr)
AU3803078A (fr)
FR2415313B1 (fr)
FR2401586B1 (fr)
FR2415393B1 (fr)
DE2821484C2 (fr)
DK219978A (fr)
AU3892778A (fr)
BG26008A1 (fr)
BG25917A1 (fr)
BG26014A1 (fr)
BG26013A1 (fr)
BG26012A1 (fr)
BG26009A1 (fr)
BG25921A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse